SectorHealthcare

LocationSwitzerland

Invested2019

StatusRealized

FundBiohealth

Arvelle Therapeutics

www.ArvelleTx.com

Arvelle Therapeutics is a biopharmaceutical company bringing innovative solutions to patients suffering from CNS disorders.

Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders. Arvelle is responsible for the development and commercialization of cenobamate, an investigational antiepileptic drug, in the European market. Arvelle is headquartered in Switzerland and received one of the largest initial financing commitments for a European-focused biopharmaceutical company.

×